small is powerfulⓇ
NanoImprove the performance of your small- and large-molecule formulations — from early development through to lifecycle management — by enabling higher drug loads in smaller tablets, in subcutaneous injections, and alternative delivery formats.
We can NanoImprove your Medicine:
Small molecules
Achieve improved bioavailability, higher drug loading and novel drug delivery for your small molecule therapeutics, enabled by best-in-class nanotechnology, expert formulation and scalable GMP supply.
Biologics
Achieve higher drug loading, long acting delivery and alternate routes of administration for your proteins, peptides and bio formulations with unique bio nanoparticles that enable superior performance.
Formulation
Deliver optimized formulation and enable more acceptable tablet regimens, and alternative delivery routes including subcutaneous and long-acting injectables, and inhaled dose forms.
GMP Manufacturing
Reliable clinical- and commercial-scale GMP supply of nanoformed API through a scalable and green process, including high potency handling.
Nanoforming Biologics & GLP-1s: From I.V. to Sub Q & Inhaled Delivery
Designing the most patient-centric and effective treatment options are key for those pharmaceutical companies developing and marketing high value biological therapies. Nanoforming biologics and peptides simplifies dose regimens and unlocks new delivery routes to enhance patient comfort, compliance and reduce healthcare costs.
Improving bioavailability
Many of the latest generation of small molecule drugs in development exhibit increased molecular weights and lipophilicity. Today’s novel, complex molecules present not only biopharmaceutical challenges such as poor solubility and bioavailability, but also handling and manufacturing challenges.
Enabling Subcutaneous Delivery for Improved Patient Compliance & Healthcare System Efficiencies
Nanoform Biologics’ high-dose subcutaneous delivery platform represents a significant advancement in the field of biologics.
Expanding Opportunities for Inhaled Drug Delivery
Whether to treat localised respiratory disease, or because the lung provides a fast, non-invasive, and efficient route of delivery for systemic effect, the administration of pharmaceuticals to the lung is gaining increased attention; even beyond treatments for globally prevalent diseases like asthma and chronic obstructive pulmonary disease (COPD).
An overview of Nanoform’s Development Capabilities
Video showcases Nanoform’s state-of-the-art development capabilities, led by our Chief Commercial Officer, Christian Jones.
An overview of Nanoform’s Manufacturing Capabilities
Video showcases Nanoform’s state-of-the-art manufacturing capabilities, led by our Head of Manufacturing, Dr David Rowe.
Nanoform Biologics
Nanoform Biologics can deliver your large molecule products in more stable powdered forms, as high concentration injections, or for inhaled delivery.
LATEST PRESS RELEASES & NEWS
To read more of our latest news and see our recent articles and videos, visit our media centre
Harness the power of AI to discover if your molecule could achieve CESS®-powered success, try STARMAP® for yourself today with our online tool.
Subscribe to hear the latest news about
Loading...
